Clinical trials: Macular Dystrophy With Flecks, Type 1

Dry AMD, Stargardt Disease 1

Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease

• Completed
• Age: 18 to 85 years

Prospective, randomised, double-blind study to assess the Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease (Macular Degeneration Omega-3 Study - MADEOS.

Trial name

MADEOS (NCT03297515)

Testing

Madeos

Where

5 sites in France, Germany and 1 more

Volunteers

32 people

Sponsor

Ophthalmos Research and Education Institute